Compare LDOS & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LDOS | ZBH |
|---|---|---|
| Founded | 1969 | 1927 |
| Country | United States | United States |
| Employees | 47000 | N/A |
| Industry | EDP Services | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 19.5B |
| IPO Year | 2005 | 2001 |
| Metric | LDOS | ZBH |
|---|---|---|
| Price | $158.78 | $86.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 19 |
| Target Price | ★ $211.33 | $104.76 |
| AVG Volume (30 Days) | 1.1M | ★ 1.8M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | 1.04% | ★ 1.09% |
| EPS Growth | ★ 20.82 | N/A |
| EPS | ★ 11.14 | 3.55 |
| Revenue | ★ $17,174,000,000.00 | $8,231,500,000.00 |
| Revenue This Year | $5.35 | $4.93 |
| Revenue Next Year | $3.97 | $3.72 |
| P/E Ratio | ★ $14.90 | $24.88 |
| Revenue Growth | 3.07 | ★ 7.20 |
| 52 Week Low | $128.32 | $84.59 |
| 52 Week High | $205.77 | $114.44 |
| Indicator | LDOS | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 30.84 | 30.61 |
| Support Level | $158.67 | $85.23 |
| Resistance Level | $165.66 | $96.45 |
| Average True Range (ATR) | 4.05 | 2.50 |
| MACD | -1.02 | -1.03 |
| Stochastic Oscillator | 7.71 | 0.27 |
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.